(EMAILWIRE.COM, February 18, 2019 ) The global cardiovascular ultrasound system market is projected to reach USD 1.66 Billion by 2021 from USD 1.27 Billion in 2016, at a CAGR of 5.4% from 2016 to 2021.

In this report, the global market is segmented on the basis of test type, technology, device display, end user, and region.

GE Healthcare (U.S.) is the largest player in the global cardiovascular ultrasound systems market.

The company focuses on growth strategies such as product launches, acquisitions, expansions, agreements, collaborations, and partnerships, in order to sustain its foothold in the market.

For instance, in August 2016, the company launched the Vivid iq, a high-end portable, compact cardiovascular ultrasound product at the European Society of Cardiology Congress in Rome, Italy. This launch strengthened the company’s echocardiography product portfolio. In September 2015, GE Healthcare established its new business unit-Sustainable Healthcare Solutions (SHS) at New York City, U.S.

Recent Developments:
-In 2015, GE Healthcare signed a memorandum of understanding with the Oregon Health & Science University (U.S.) to undertake collaborative R&D studies in the field of cardiovascular imaging & treatment as well as in big data research

-In 2015, GE Healthcare launched a new 4D cardiac ultrasound software—cSound—for three new ultrasound systems, namely, VividS70, VividE90, and VividE95 in the U.S. and some countries in Europe, Asia, and LatinAmerica.

To Know More @ https://www.marketsandmarkets.com/Market-Reports/cardiovascular-ultrasound-system-market-50389652.html